Reconstruction, Energy Calibration, and Identification of Hadronically Decaying Tau Leptons in the ATLAS Experiment for Run-2 of the LHC

Dirk Duschinger, H. Fox, Pa. Malecki(Institute of Nuclear Physics, Polish Academy of Sciences), W. Davey, N. Rompotis, Q. Buat, B. Martin dit Latour, S. Hanisch, B. Burghgrave, M. K. Ayoub, E. V. Bouhova-Thacker, Nils Ruthmann, A. J. Parker, A. Karamaoun, Lorenz Hauswald, Pedro Henrique Sales de Bruin, Justin Griffiths, Matthew Beckingham, A. Soloshenko, P. Pétroff, E. Carquín, A. Andreazza, L. Y. Shan, Pier-Olivier Deviveiros, M. Janus

Unknown

November 3, 2015

Cited by 65

Related Papers

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

|Allergy|2004|1.1k

FCC-ee: The Lepton Collider

|The European Physical Journal Special Topics|2019|919

FCC Physics Opportunities

|The European Physical Journal C|2019|679

FCC-hh: The Hadron Collider

|The European Physical Journal Special Topics|2019|638

HE-LHC: The High-Energy Large Hadron Collider

|The European Physical Journal Special Topics|2019|193